Rocket Pharmaceuticals, Inc. (RCKT) is currently at $6.52, down $1.07 or 14.11%
--Would be lowest close since Sept. 22, 2017, when it closed at $6.20
--On pace for largest percent decrease since March 14, 2022, when it fell 16.12%
--Currently down four of the past five days
--Currently down two consecutive days; down 17.27% over this period
--Worst two-day stretch since the two days ending Dec. 23, 2022, when it fell 18.61%
--Down 31.01% month-to-date
--Down 48.14% year-to-date
--Down 90.77% from its all-time closing high of $70.60 on July 24, 2015
--Down 75.60% from 52 weeks ago (April 1, 2024), when it closed at $26.72
--Down 75.6% from its 52-week closing high of $26.72 on April 1, 2024
--Would be a new 52-week closing low
--Traded as low as $6.26; lowest intraday level since Sept. 25, 2017, when it hit $6.12
--Down 17.52% at today's intraday low; largest intraday percent decrease since Dec. 22, 2022, when it fell as much as 24.44%
All data as of 1:29:20 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 31, 2025 13:33 ET (17:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.